IMAX (NYSE:IMAX) Downgraded by Wall Street Zen to “Buy”

IMAX (NYSE:IMAX) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

Other research analysts also recently issued reports about the stock. The Goldman Sachs Group upgraded shares of IMAX from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $22.00 to $34.00 in a research report on Tuesday, November 25th. Barrington Research reiterated an “outperform” rating and issued a $42.00 price target on shares of IMAX in a research note on Monday, January 26th. Macquarie Infrastructure upped their price objective on IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. B. Riley Financial reaffirmed a “buy” rating on shares of IMAX in a research note on Monday, December 8th. Finally, Benchmark boosted their target price on IMAX from $42.00 to $44.00 and gave the stock a “buy” rating in a research note on Thursday. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, IMAX presently has a consensus rating of “Moderate Buy” and an average target price of $43.00.

IMAX Stock Up 2.6%

IMAX opened at $42.86 on Friday. The stock has a market capitalization of $2.31 billion, a price-to-earnings ratio of 69.13, a P/E/G ratio of 2.07 and a beta of 0.38. IMAX has a twelve month low of $20.48 and a twelve month high of $43.16. The company has a 50-day simple moving average of $36.44 and a 200 day simple moving average of $33.99.

IMAX (NYSE:IMAX) last released its earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.43 by $0.15. IMAX had a net margin of 8.50% and a return on equity of 13.69%. The firm had revenue of $125.21 million for the quarter, compared to analyst estimates of $120.30 million. During the same period last year, the firm earned $0.27 EPS. The business’s quarterly revenue was up 35.1% compared to the same quarter last year. Sell-side analysts anticipate that IMAX will post 0.91 EPS for the current fiscal year.

Institutional Trading of IMAX

A number of hedge funds have recently made changes to their positions in the company. Aurora Investment Counsel grew its holdings in shares of IMAX by 0.4% during the third quarter. Aurora Investment Counsel now owns 70,235 shares of the company’s stock worth $2,300,000 after purchasing an additional 308 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in IMAX by 43.8% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,041 shares of the company’s stock worth $34,000 after acquiring an additional 317 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its position in IMAX by 28.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,489 shares of the company’s stock valued at $55,000 after acquiring an additional 332 shares during the period. GAMMA Investing LLC increased its position in IMAX by 22.3% in the 4th quarter. GAMMA Investing LLC now owns 1,874 shares of the company’s stock valued at $69,000 after acquiring an additional 342 shares during the period. Finally, Arizona State Retirement System raised its stake in shares of IMAX by 2.8% during the third quarter. Arizona State Retirement System now owns 13,517 shares of the company’s stock valued at $443,000 after acquiring an additional 364 shares during the last quarter. 93.51% of the stock is owned by institutional investors and hedge funds.

IMAX News Roundup

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Q4 earnings beat and strong growth — IMAX reported $0.58 EPS vs. $0.43 consensus and revenue of $125.2M (up ~35% y/y), driven by blockbuster titles and higher profitability. This is the primary catalyst for the stock move. Earnings Report
• Positive Sentiment: Analyst upgrades — JPMorgan raised its price target to $48 and kept an “overweight” rating, signaling meaningful upside; Benchmark also raised its target to $44 and reiterated a “buy”. Analyst bullishness supports further upside sentiment. Analyst Note Benchmark Note
• Positive Sentiment: Strong box-office backdrop and targets — Management outlined a $1.4B global box-office target for 2026 and is expanding premium content and network reach, suggesting recurring upside if tentpoles and slate perform. Box Office Target
• Positive Sentiment: Content wins and programming diversification — Dune 3 secured exclusive IMAX opening-weekend play in select markets (good for premium ticket sales), Studio Ghibli re-releases and live F1 broadcasts broaden non-traditional revenue streams. Dune 3 Article Ghibli Re-release F1 in IMAX
• Neutral Sentiment: Institutional support — Rosenblatt reiterated a buy and other boutiques remain constructive; this helps sentiment but is not new fundamental strength. Rosenblatt Note
• Neutral Sentiment: Investor materials available — The earnings call transcript and slide deck were published for deeper inspection; useful for gauging guidance and margin drivers but not an immediate price catalyst. Earnings Call Transcript
• Negative Sentiment: Opening-weekend windowing risk — Major title Avengers: Doomsday will not have an IMAX opening-weekend release in the U.S., which could blunt upside from that particular tentpole and offset some gains from other exclusives. Avengers Windowing

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.